Q linea AB

QLINEA.ST · Health Technology · Medical Specialties · SE

122 employees · qlinea.com

About

Q-linea AB develops and manufactures in-vitro diagnostic solutions for infectious diseases, focusing on antibiotic susceptibility testing. The company's core product, ASTar, is a fully-automated instrument that provides susceptibility profiles within three to six hours directly from positive blood cultures. This enables early targeted antibiotic administration for sepsis identification in hospital patients, primarily serving hospital laboratories. The firm measures bacteria's antimicrobial susceptibility using its own disposables, which are integral to the ASTar system's operation. Q-linea AB's revenue model is based on selling the ASTar instrument and its associated disposables to hospital laboratories. The company's product is specifically designed for sepsis identification in hospital settings, where rapid and accurate antibiotic susceptibility testing is critical. By providing a faster solution than traditional methods, Q-linea targets hospital labs seeking to improve patient outcomes in sepsis cases. The company operates as a holding company with a focus on developing and manufacturing IVD solutions. Its primary customers are hospital laboratories, which purchase the ASTar system and disposables to streamline their diagnostic processes. The firm's business model centers on the sale of both the instrument and the consumable disposables, creating recurring revenue streams from ongoing disposables usage.

Annual results

Reported figures, SEK · revenue up 450.0% in 2025

YearRevenueNet incomeNet marginFree cash flow
202511.0M-182M-1654.5%—
20242.0M-216M-10800.0%—
20234.0M-229M-5725.0%—
202212.0M-275M-2291.7%—
20219.0M-233M-2588.9%—

QLINEA.ST in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Q linea AB are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Q linea AB (QLINEA.ST) — company profile and financials · MarketPulse